Inflammatory response and postoperative kidney failure in patients with diabetes type 2 or impaired glucose tolerance undergoing heart valve surgery

Kardiologia Polska

Volumn 68, Issue 5, 2010, Pages 530-536

  Zakrzewski, Dariusz ^a   Janas, Jadwiga ^a   Heretyk, Hanna ^a   Stȩpińska, Janina ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Acquired heart valve disease; Cytokines; Diabetes; Postoperative kidney failure

Indexed keywords

CREATININE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC PATIENT; FEMALE; HEART EJECTION FRACTION; HEART VALVE SURGERY; HEMODIALYSIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; VALVULAR HEART DISEASE;

EID: 77953767434     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bucerius J, Gummert JF, Walther T et al. Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg, 2003; 51: 113-118.
2. Morricone L, Ranucci M, Denti S et al. Diabetes and complications after cardiac surgery: comparison with a non-diabetic population. Acta Diabetol, 1999; 36: 77-84.
3. Burns KE, Chu MW, Novick RJ et al. Perioperative N-acetyl-cysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial. JAMA, 2005; 294: 342-350.
4. Rahmanian PB, Filsoufi F, Castillo JG et al. Predicting post-operative renal failure requiring dialysis and an analysis of long-term outcome in patients undergoing valve surgery. J Heart Valve Dis, 2008; 17: 657-665.
5. Cardellini M, Andreozzi F, Laratta E et al. Plasma interlekin-6 are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev, 2007; 23: 141-145.
6. Pereira FO, Frode TS, Medeiros YS. Evaluation of tumor necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites and lipids as inflammatory markers in type 2 diabetes mellitus. Mediators Inflamm, 2006; 1: 62-69.
7. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev, 2003; 24: 278-301. (Pubitemid 36724371)
8. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concetrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation, 2002; 106: 2067-2072.
9. Navarro-Gonzales JF, Jarque A, Muros M et al. Tumor necrosis factor-alpha as a therapeutic taget for diabetic nephropathy. Cytokine Growth Factor Re, 2009; 20: 165-173.
10. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothoracic Surg, 2002; 21: 232-244.
11. Rahmanian PB, Filsoufi F, Castillo JG et al. Predicting post-operative renal failure requiring dialysis and an analysis of long-term outcome in patients undergoing valve surgery. J Heart Valve Dis, 2008; 17: 657-665.
12. Lombardi R, Ferreiro A. Risk factors for acute kidney injury after cardiac surgery is different according to the level of baseline renal function. Ren Fail, 2008; 30: 155-160.
13. Morariu AM, Loef BG, Aarts LP et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting. Chest, 2005; 128: 2677-2687.
14. Chello M, Mastroroberto P, Cirillo F et al. Neutrophil-endothelial cells modulation in diabetic patients undergoing coronary artery bypass grafting. Eur J Cardio-Thorac Surg, 1998; 14: 372-379.
15. Gokulakrishnan K, Mohanavalli KT, Monickaraj F et al. Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and type 2 diabetes patients. Mol Cell Biochem, 2009; 324: 173-181.
16. Diegeler A, Doll N, Rauch T et al. Humoral immune response during coronary artery bypass grafting. Circulation, 2000, 102: III-95-III-100.
17. Menasche P. The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg, 2001; 72: 2260-2266.
18. Drabe N, Zund G, Grunenfelder J et al. Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. Eur J Cardio-Thorac Surg, 2001; 20: 609-613.
19. Daemen MA, van de Ven MW, Heineman E et al. Involvement of endogenous interleukin-10 and TNF alpha in renal ischemia-reperfusion injury. Transplantation, 1999; 67: 792-800. (Pubitemid 29169122)
20. Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilatation of normal rat arterioles. Am J Physiol, 1993; 265: H219-H225.
21. Jin JS, Bhlen HG. Non-insulin-dependent diabetes and hyperglycemia impair rat intestinal flow-mediated regulation. Am J Physiol, 1997; 272: H728-H734. (Pubitemid 27142624)
22. Fedoruk LM, Wang H, Conaway MR et al. Statin therpay improves outcomes after valvular heart surgery. Ann Thorac Surg, 2008; 85: 1521-1525.